Analysis of expression pattern of the gene which is related to the radiation sensitivity in urothelial cancer and its clinical application
尿路上皮癌放射敏感性相关基因表达模式分析及临床应用
基本信息
- 批准号:15390482
- 负责人:
- 金额:$ 5.12万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (B)
- 财政年份:2003
- 资助国家:日本
- 起止时间:2003 至 2004
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
From the present project, the following results were obtained.1.Initially, we evaluated radiation sensitivity in the nude mice transplanted with human bladder cancer cell lines. Utilizing this model, we set up the radiation exposure condition (single time irradiation of 5 Gy) and confirmed that tumor growth delayd reaction could be evaluated as an endpoint of radiation sensitivity.2.The establishment of Xenogarft model : Tumor growth was observed in 18 mice (60%, 18/30). Histologically, 15 of the18 were epithelial carcinomas similar to the original tumors, resulting in a 50% (15/30) take rate. No correlation was found between the tumor take rate and the clinicopathologic features, TP53 mutational status, or Ki67 LI of the patients' tumors. Of the 15 xenografts, 11 xenografts were passed from 3 to 10 generations. TP53 mutational status remained stable during the passages, though the Ki67 LI slightly increased in the majority of xenografts. Specific growth delay after irradiation in the 4 xenografts was observed independent of the original tumor growth speed and Ki67 LI.3.Radiological growth delay assay : To assess the usefulness of these xenografts for therapeutic simulation, we performed radiological growth-delay assay in 4 xenografts and examined the relation between the responses and the biological parameters of xenograft tumors. The radiation response considerably varied among the 4 models. Absolute growth delay ranged from 20.3+2.4 (mean+standard error) to 76.4±7.4 days. Specific growth delay (SGD) was not associated with in vivo tumor growth speed or the Ki67 Il. The smallest SGD value was observed in the No.3 model which harbored TP53 gene mutation.
从目前的项目中,得到了以下结果:最初,我们评估了裸鼠移植人类膀胱癌细胞系的辐射敏感性。利用该模型,我们设置了5 Gy单次照射的照射条件,并证实肿瘤生长延迟反应可以作为辐射敏感性的评价终点。Xenogarft模型的建立:18只小鼠(60%,18/30)观察到肿瘤生长。组织学上,18例中有15例为上皮性癌,与原肿瘤相似,发生率为50%(15/30)。肿瘤发生率与患者肿瘤的临床病理特征、TP53突变状态、Ki67 LI均无相关性。15例异种移植物中,11例为3 ~ 10代传代。TP53突变状态在传代过程中保持稳定,尽管Ki67 LI在大多数异种移植物中略有增加。4例异种移植物辐照后特异性生长延迟与原肿瘤生长速度和ki67li无关。放射生长延迟试验:为了评估这些异种移植物在治疗模拟中的有效性,我们对4个异种移植物进行了放射生长延迟试验,并检查了反应与异种移植物肿瘤生物学参数之间的关系。4种模式的辐射响应差异很大。绝对生长延迟从20.3+2.4(平均值+标准误差)到76.4±7.4天。特异性生长延迟(Specific growth delay, SGD)与体内肿瘤生长速度或ki67il无关。在TP53基因突变的3号模型中,SGD值最小。
项目成果
期刊论文数量(18)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Gene-expression profile changes correlated with tumor progression and lymph node metastasis in Esophageal cancer
- DOI:10.1158/1078-0432.ccr-04-0048
- 发表时间:2004-06-01
- 期刊:
- 影响因子:11.5
- 作者:Tamoto, E;Tada, M;Katoh, H
- 通讯作者:Katoh, H
進行性尿路上皮癌に対するTIN(Paclitaxel, Ifosfamide, Nedaplatin)療法
TIN(紫杉醇、异环磷酰胺、奈达铂)治疗晚期尿路上皮癌
- DOI:
- 发表时间:2004
- 期刊:
- 影响因子:0
- 作者:鈴木 信;篠原信雄;他
- 通讯作者:他
Prediction of lymph node metastasis by analysis of gene expression profiles in non-small cell lung cancer.
- DOI:10.1016/j.jss.2004.06.002
- 发表时间:2004-11
- 期刊:
- 影响因子:0
- 作者:M. Takada;M. Tada;Eiji Tamoto;Akiko Kawakami;Katsuhiko Murakawa;G. Shindoh;Ken-ichi Teramoto;A. Matsunaga;K. Komuro;M. Kanai;Y. Fujiwara;K. Shirata;Norihiro Nishimura;M. Miyamoto;S. Okushiba;S. Kondo;J. Hamada;H. Katoh;T. Yoshiki;T. Moriuchi
- 通讯作者:M. Takada;M. Tada;Eiji Tamoto;Akiko Kawakami;Katsuhiko Murakawa;G. Shindoh;Ken-ichi Teramoto;A. Matsunaga;K. Komuro;M. Kanai;Y. Fujiwara;K. Shirata;Norihiro Nishimura;M. Miyamoto;S. Okushiba;S. Kondo;J. Hamada;H. Katoh;T. Yoshiki;T. Moriuchi
Paclitaxl, Ifomide, Nedaplatin (TIN) for patients with metastatic urothelial cancer
紫杉醇、异福胺、奈达铂 (TIN) 用于治疗转移性尿路上皮癌患者
- DOI:
- 发表时间:2004
- 期刊:
- 影响因子:0
- 作者:Suzuki S;Shinohara N;et al.
- 通讯作者:et al.
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SHINOHARA Nobuo其他文献
SHINOHARA Nobuo的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('SHINOHARA Nobuo', 18)}}的其他基金
Discovery of diagonositc and therapeutic biomarker by circulating tumor endothelial cells in metastatic renal cell carcinoma
通过循环肿瘤内皮细胞发现转移性肾细胞癌的诊断和治疗生物标志物
- 批准号:
23592320 - 财政年份:2011
- 资助金额:
$ 5.12万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Development of new screening system for anti-angiogenic drugs using tumor associated endothelial cells derived from renal cell carcinoma
使用源自肾细胞癌的肿瘤相关内皮细胞开发新的抗血管生成药物筛选系统
- 批准号:
20591847 - 财政年份:2008
- 资助金额:
$ 5.12万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Establishment of gene therapy against bladder cancer utilizing gelsolin gene and a dominant negative ras mutant
利用凝溶胶蛋白基因和显性失活ras突变体建立针对膀胱癌的基因治疗
- 批准号:
12470326 - 财政年份:2000
- 资助金额:
$ 5.12万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Preclinical study for gene therapy against bladder cancer utilizing gelsolin gene and a dominant negative ras mutant
利用凝溶胶蛋白基因和显性失活ras突变体治疗膀胱癌的临床前研究
- 批准号:
10470327 - 财政年份:1998
- 资助金额:
$ 5.12万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Growth suppression of renal cell carcinoma cell lines by a dominant negative H-ras mutant
显性失活 H-ras 突变体对肾细胞癌细胞系生长的抑制作用
- 批准号:
08671786 - 财政年份:1996
- 资助金额:
$ 5.12万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
相似海外基金
Optimizing head and Neck Tumour And Symptom Control in Patients Unable to Tolerate Curative (Radio)Therapy: a Phase III trial Comparing Stereotactic Body Radiation Therapy (SBRT) to Standard Palliative Radiation Treatment (ON-TASC Study)
优化无法耐受根治性(放射)治疗患者的头颈肿瘤和症状控制:比较立体定向全身放射治疗 (SBRT) 与标准姑息性放射治疗的 III 期试验(ON-TASC 研究)
- 批准号:
477985 - 财政年份:2023
- 资助金额:
$ 5.12万 - 项目类别:
Operating Grants
Cellular senescence induced by chemo/radio-therapy as new therapeutic opportunity of mammary tumors.
化疗/放疗诱导的细胞衰老是乳腺肿瘤的新治疗机会。
- 批准号:
16K10486 - 财政年份:2016
- 资助金额:
$ 5.12万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Magnetic field and radio frequency background simulations for a real time image guided adaptive radio therapy cancer treatment unit
实时图像引导自适应放射治疗癌症治疗装置的磁场和射频背景模拟
- 批准号:
348155-2007 - 财政年份:2008
- 资助金额:
$ 5.12万 - 项目类别:
Postgraduate Scholarships - Doctoral
Effects of hypoxia-targeted therapies combined with chemo-radio therapy in oral squamous cell carcinoma cells
缺氧靶向治疗联合放化疗对口腔鳞癌细胞的影响
- 批准号:
20390480 - 财政年份:2008
- 资助金额:
$ 5.12万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Development of the energy analyzer of Auger electron emitted from radio pharmaceuticals for local controlled radio therapy.
开发用于局部控制放射治疗的放射性药物发射的俄歇电子能量分析仪。
- 批准号:
19790863 - 财政年份:2007
- 资助金额:
$ 5.12万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
Magnetic field and radio frequency background simulations for a real time image guided adaptive radio therapy cancer treatment unit
实时图像引导自适应放射治疗癌症治疗装置的磁场和射频背景模拟
- 批准号:
348155-2007 - 财政年份:2007
- 资助金额:
$ 5.12万 - 项目类别:
Postgraduate Scholarships - Doctoral
Combination of gene therapy with targeting-radio-therapy against prostate cancer using anti-PSA antibody
使用抗 PSA 抗体联合基因治疗与靶向放射治疗治疗前列腺癌
- 批准号:
09470344 - 财政年份:1997
- 资助金额:
$ 5.12万 - 项目类别:
Grant-in-Aid for Scientific Research (B)














{{item.name}}会员




